JPMorgan Downgrades Teva Pharma (TEVA) to Underweight

November 4, 2013 6:48 AM EST
Get Alerts TEVA Hot Sheet
Price: $65.02 +3.32%

Rating Summary:
    24 Buy, 12 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 19 | Down: 15 | New: 31
Trade TEVA Now!
Join SI Premium – FREE
JPMorgan downgraded Teva Pharma (NYSE: TEVA) from Neutral to Underweight with a price target of $38.00 (from $43.00).

For an analyst ratings summary and ratings history on Teva Pharma click here. For more ratings news on Teva Pharma click here.

Shares of Teva Pharma closed at $37.12 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change, Downgrades

Related Entities


Add Your Comment